ReviewFrontiers in cell and developmental biology2026
PI3K/AKT/mTOR signaling at the immune checkpoint interface in lung cancer: molecular mechanisms, Tumor-Immune remodeling, therapeutic resistance, and emerging treatment strategies.
Hongliang Jin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.